Uroplasty Inc (UPI.OQ)

UPI.OQ on NASDAQ Stock Exchange Capital Market

2.27USD
31 Jul 2013
Price Change (% chg)

$-0.01 (-0.44%)
Prev Close
$2.28
Open
$2.29
Day's High
$2.29
Day's Low
$2.25
Volume
500
Avg. Vol
20,049
52-wk High
$4.32
52-wk Low
$1.69

UPI.OQ

Chart for UPI.OQ

About

Uroplasty, Inc. is a medical device company that develops, manufactures and markets products for the treatment of voiding dysfunctions. The Company’s primary focus is on two products: the Urgent PC Neuromodulation system and Macroplastique Implants. The Urgent PC system is a United States Food and Drug Administration (FDA)-appro... (more)

Overall

Beta: 1.02
Market Cap (Mil.): $47.10
Shares Outstanding (Mil.): 20.93
Dividend: --
Yield (%): --

Financials

  UPI.OQ Industry Sector
P/E (TTM): -- 27.50 37.76
EPS (TTM): -0.16 -- --
ROI: -17.82 9.26 18.76
ROE: -18.40 12.54 19.59
Search Stocks

Uroplasty places CFO on leave, delays filing annual report

- Medical device maker Uroplasty Inc said it placed Chief Financial Officer Mahedi Jiwani on administrative leave pending a review of internal financial controls, and would delay filing its annual report for the year ended March 31.

14 Jun 2013

Competitors

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Reuters Investment Profile
$20.00
Provider: Zacks Investment Research Inc.
$12.00
Provider: Zacks Investment Research Inc.
$12.00
Provider: Zacks Investment Research Inc.
$12.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks